Atosiban Acetate
Spezifikationen
914453-95-5CAS-Nummer
acetic acid;(2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacIUPAC-Name
C45H71N11O14S2Chemische Formel
1054.2 g/molMolekulargewicht
Atosiban acetate; 914453-95-5; 0P5DNO7CEF; UNII-0P5DNO7CEF; ATOSIBAN ACETATE [WHO-DD]; ATOSIBAN ACETATE [EMA EPAR]; GLYCINAMIDE, O-ETHYL-N-(3-MERCAPTO-1-OXOPROPYL)-D-TYROSYL-L-ISOLEUCYL-L-THREONYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-ORNITHYL-, CYCLIC (1->5)-DISULFIDE, ACETATE (1:1); GLYCINAMIDE, O-ETHYL-N-(3-MERCAPTO-1-OXOPROPYL)-D-TYROSYL-L-ISOLEUCYL-L-THREONYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-ORNITHYL-, CYCLIC (1->5)-DISULFIDE, MONOACETATE (SALT); GLYCINAMIDE, O-ETHYL-N-(3-MERCAPTO-1-OXOPROPYL)-D-TYROSYL-L-ISOLEUCYL-L-THREONYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-ORNITHYL-, CYCLIC (1->5)-DISULPHIDE, ACETATE (1:1); GLYCINAMIDE, O-ETHYL-N-(3-MERCAPTO-1-OXOPROPYL)-D-TYROSYL-L-ISOLEUCYL-L-THREONYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-ORNITHYL-, CYCLIC (1->5)-DISULPHIDE, MONOACETATE (SALT); OXYTOCIN, 1-(3-MERCAPTOPROPANOIC ACID)-2-(O-ETHYL-D-TYROSINE)-4-L-THREONINE-8-L-ORNITHINE-, ACETATE; DTXSID60238569; RefChem:115453; DTXCID60161060; MFCD08692014; Antocin acetate; acetic acid;(2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide; Tractocile;; C45H71N11O14S2; Atosiban (as acetate); SCHEMBL4410202; CHEMBL5315050; yrrolidine-2-carboxamide acetate; WZG0202; GLXC-23433; EX-A7437; AKOS030485985; FA40914; DA-50781; 5386S; A7657; G13510; F863787; Q27237053; (Deamino-Cys1,D-Tyr(Et)2,Thr4,Orn8)-Oxytocin Acetate; 2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)p; (S)-N-((S)-5-amino-1-((2-amino-2-oxoethyl)amino)-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-((S)-sec-butyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,; (S)-N-((S)-5-amino-1-((2-amino-2-oxoethyl)amino)-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-((S)-sec-butyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide acetate; acetic acid;(2S)-N-[(1S)-4-amino-1-[(2-amino-2-oxo-ethyl)carbamoyl]butyl]-1-[(4R,7S,10S,13S,16R)-7-(2-amino-2-oxo-ethyl)-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamideSynonyme
Produkte, die Atosiban Acetate enthalten
트랙시반주(아토시반아세트산염)아시반주사(아토시반아세트산염)트랙토실주(아토시반아세트산염)ATOSIBAN EVER PHARMA 75 MG/10 ML CONCENTRADO PARA SOLUCION PARA PERFUSIONATOSIBAN EVER PHARMA 6,75 MG/0,9 ML SOLUCION INYECTABLE EFGATOSIBAN EVER PHARMA 37,5 MG/5 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFGATOSIBAN ALTAN 6.75 MG/0.9 ML SOLUCION INYECTABLE EFGATOSIBAN ALTAN 37,5 MG/5 ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFGTRACTOCILE 6,75 mg/0,9 ml, solution injectableTRACTOCILE 37,5 mg/5 ml, solution à diluer pour perfusionATOSIBAN SUN 6,75 mg/0,9 ml, solution injectableATOSIBAN SUN 37,5 mg/5 ml, solution à diluer pour perfusion
Seite 1 von 2
Unternehmen, die Atosiban Acetate verkaufen
동국
동국제약(주)Republic of Korea한림
한림제약(주)Republic of KoreaEV
EVER VALINJECTAustriaSJ
Shenzhen JYMed Technology Co., Ltd.ChinaHH
HANGZHOU HUADI GROUP CO., LTD.ChinaSP
SUN PHARMACEUTICAL INDUSTRIES EUROPENetherlandsSeite 1 von 2